The CAR T Vision Steering Committee members wish to double the number of eligible patients receiving chimeric antigen ...

Zevaskyn, the first gene therapy for recessive dystrophic epidermolysis bullosa, showed significant wound healing in phase 3 ...

A modified immunotherapy regimen for advanced melanoma showed a 49% response rate and extended median overall survival to 42 ...

As the number of patients with multiple myeloma and lymphoma treated with CAR-T therapy increases, health systems are ...

The use of an older medication at the time of surgery can reduce the need for red blood cell transfusions, according to a ...

Chimeric antigen receptor (CAR) T-cell therapy can cure certain types of blood cancer, but cost and a general lack of ...

Strong positive results of a novel combination of two immunotherapy drugs as a treatment for multiple myeloma after other treatments have failed suggest the combination could be a “functional cure,” ...

Jaypirca (pirtobrutinib) improved progression-free survival in treatment-naïve patients with chronic lymphocytic leukemia (CLL) and small lymphocytic lymphoma (SLL) when compared with bendamustine ...

Schizophrenia spectrum disorders significantly increase cardiovascular and metabolic disease risks, partly due to antipsychotic-induced weight gain and glucose dysregulation.

According to a report written by sister publication Dermatology Times (DT) in November, research from the 2025 Inflammatory Skin Disease Summit noted that itch can signal inflammation in the body.

Venclexta-azacitidine combination offered better responses with less hospitalization and lower symptom burden compared with ...

In this interview, George Eastwood, executive director of the Emily Whitehead Foundation and CAR T Vision steering committee member discusses barriers and strategies for expanding access to CAR T-cell ...